These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36559537)

  • 21. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.
    Siriwattananon K; Manopwisedjaroen S; Shanmugaraj B; Rattanapisit K; Phumiamorn S; Sapsutthipas S; Trisiriwanich S; Prompetchara E; Ketloy C; Buranapraditkun S; Wijagkanalan W; Tharakhet K; Kaewpang P; Leetanasaksakul K; Kemthong T; Suttisan N; Malaivijitnond S; Ruxrungtham K; Thitithanyanont A; Phoolcharoen W
    Front Plant Sci; 2021; 12():682953. PubMed ID: 34054909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs.
    Ruocco V; Vavra U; König-Beihammer J; Bolaños Martínez OC; Kallolimath S; Maresch D; Grünwald-Gruber C; Strasser R
    Front Plant Sci; 2023; 14():1275228. PubMed ID: 37868317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
    Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X.
    Mardanova ES; Blokhina EA; Tsybalova LM; Peyret H; Lomonossoff GP; Ravin NV
    Front Plant Sci; 2017; 8():247. PubMed ID: 28293244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
    Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
    Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
    Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
    mBio; 2021 May; 12(3):. PubMed ID: 33975938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.
    Gattinger P; Kratzer B; Tulaeva I; Niespodziana K; Ohradanova-Repic A; Gebetsberger L; Borochova K; Garner-Spitzer E; Trapin D; Hofer G; Keller W; Baumgartner I; Tancevski I; Khaitov M; Karaulov A; Stockinger H; Wiedermann U; Pickl WF; Valenta R
    Allergy; 2022 Aug; 77(8):2431-2445. PubMed ID: 35357709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
    Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant-produced Recombinant Influenza A Vaccines Based on the M2e Peptide.
    Mardanova ES; Ravin NV
    Curr Pharm Des; 2018; 24(12):1317-1324. PubMed ID: 29521217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2.
    Meena J; Singhvi P; Srichandan S; Dandotiya J; Verma J; Singh M; Ahuja R; Panwar N; Wani TQ; Khatri R; Siddiqui G; Gupta A; Samal S; Panda AK
    Eur J Pharm Biopharm; 2022 Jul; 176():43-53. PubMed ID: 35589003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge.
    Mezhenskaya D; Isakova-Sivak I; Matyushenko V; Donina S; Rekstin A; Sivak K; Yakovlev K; Katelnikova A; Kryshen K; Makarov V; Rudenko L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.
    Talbot HK; Rock MT; Johnson C; Tussey L; Kavita U; Shanker A; Shaw AR; Taylor DN
    PLoS One; 2010 Dec; 5(12):e14442. PubMed ID: 21203437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model.
    Koonpaew S; Kaewborisuth C; Srisutthisamphan K; Wanitchang A; Thaweerattanasinp T; Saenboonrueng J; Poonsuk S; Jengarn J; Viriyakitkosol R; Kramyu J; Jongkaewwattana A
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
    Jeong H; Choi YM; Seo H; Kim BJ
    Front Immunol; 2021; 12():637654. PubMed ID: 33732258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.
    Wang BZ; Gill HS; He C; Ou C; Wang L; Wang YC; Feng H; Zhang H; Prausnitz MR; Compans RW
    J Control Release; 2014 Mar; 178():1-7. PubMed ID: 24417966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation and immungenicity of recombinant protein containing intramolecular adjuvant in SARS-CoV-2 RBD domain].
    Jiang J; Wang Y; Li Y; Wang J; Zhang Y; Wang X; Wang X; Zhang H
    Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3353-3362. PubMed ID: 36151805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA vaccine targeting the ectodomain of influenza M2 protein to endolysosome pathway enhances anti-M2e protective antibody response in mice.
    Hollý J; Tomčíková K; Vozárová M; Fogelová M; Jakubcová L; Varečková E; Kostolanský F
    Acta Virol; 2021; 65(2):181-191. PubMed ID: 34130469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.
    Maharjan PM; Cheon J; Jung J; Kim H; Lee J; Song M; Jeong GU; Kwon Y; Shim B; Choe S
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan.
    He Y; Yu W; Shen L; Yan W; Xiao L; Qi J; Hu T
    Int J Biol Macromol; 2022 Dec; 222(Pt A):661-670. PubMed ID: 36152702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.